SALT LAKE CITY, Nov. 30, 2021 / PRNewswire / – Sera Prognostics Inc., The Pregnancy CompanyÂ® (NASDAQ: SERA), is focused on improving maternal and newborn health by providing innovative biomarker information for doctors and patients Providing pregnancies today announced that Sandra AJ Lawrence has joined Sera’s board of directors.
“We are very pleased to have Sandra Lawrence on Sera’s board of directors,” said Gregory C. Critchfield, CEO and Chairman of Sera Prognostics. “Sandra brings her broad and in-depth leadership experience to Sera, having served on several public and private boards in a variety of respected organizations. As an operations officer in C-level leadership and finance capacities, she also has relevant first-hand knowledge and perspectives . ” on the challenges and pressures of dealing with adverse pregnancy outcomes in their service in a large, comprehensive pediatric center. We are thrilled that Sandra is helping and helping us make a meaningful and lasting difference for the well-being of all mothers and newborns. the company as we work towards long-term, sustained sales growth. “
Ms. Lawrence served as trustee of Macquarie’s Delaware Funds, director of its New York and Australian stock exchange listed DEW / VCF / DDF / VMM / VFL / IVH close-end funds, and audit and investments committees since 2021. She is a trustee of the Ivy and Waddell and Reed Mutual Funds Complex Trust and has served on the Governance Committee since 2019. Ms. Lawrence was Executive Vice President and Chief Financial Officer of Children’s Mercy Hospital, a. Comprehensive Pediatric Medical Center in Kansas City, Missouri, from 2005 to 2016; and Executive Vice President and Chief Administrative Officer of Children’s Mercy Hospital from 2016 to February 2019. She was senior vice president and treasurer of the Midwest Research Institute, an independent, not-for-profit , Kansas City, Missouri-based contract research firm and later its chief financial officer. Ms. Lawrence spent 26 years in technical or managerial positions in the architecture, real estate, investment banking, financial services, packaging, and medical research industries. Ms. Lawrence also serves on the board of directors of Evergy, Inc., a publicly traded company that provides clean, safe, and reliable energy to 1.6 million customers in Kansas and Missouri, where she serves as Chair of Nominating, Governance. acts and Corporate Responsibility Committee as well as a member of the Compensation and Leadership Development Committee. Ms. Lawrence serves on the board of directors of American Shared Hospital Services, a publicly traded company providing radiosurgery and radiation therapy equipment and services, headquartered in San Francisco, California, where she serves as chair of the audit committee and as a member of the nomination – and Corporate Governance Committee. She also serves on the board of directors as Chair of the Risk Oversight Committee and the Governance, Compliance, and Talent and Compensation Committee of Recology, a large, privately held employee stock ownership company that provides the collection and disposal of municipal solids, waste, recycling, and bio / compost to commercial and residential customers in California, Oregon, and Washington. Ms. Lawrence served as chair of the board of directors for the Heartland Chapter of the National Association of Corporate Directors (NACD), was named one of the 100 directorships, and is a NACD Board Leadership Fellow. She serves on the boards of various charitable, nonprofit, and civil society organizations, including the Hall Family Foundation, the Nelson-Atkins Museum of Art, and Women Corporate Directors. Ms. Lawrence is a graduate of Vassar College, where she received her Bachelor of Arts degree in Psychology. She also earned a Masters of Architecture from the Massachusetts Institute of Technology and a Masters in Business Administration from Harvard Business School.
New and refurbished C-arm systems. Call 702.384.0085 Today!
Quest Imaging Solutions offers all major brands of surgical C-arms (new and refurbished) and has a large inventory for sale or rent. With over 20 years of experience in the medical technology business, we can help you meet your device needs
“I am very excited to join Sera’s board of directors and work on its strategy to provide actionable information and improve the opportunity for better short and long-term quality of life for babies,” said Sandra AJ Lawrence. “I am exciting to help Sera develop innovative and comprehensive solutions for pregnant women that benefit women and babies in all communities and walks of life here in the US and abroad.”
About Sera Prognostics, Inc.
Sera Prognostics is a leading health diagnostic company dedicated to improving the lives of women and babies through precise pregnancy care. Sera’s mission is to provide doctors with vital information early on in pregnancy that will enable them to improve the health of their patients, leading to lower health care costs. Sera has a robust pipeline of innovative diagnostic tests that focus on the early prediction of the risk of preterm birth and other pregnancy complications. Sera’s Precision Medicine PreTRMÂ® test reports to a doctor about the individual risk of spontaneous premature birth in a pregnancy, enabling earlier proactive interventions in women at higher risk. Sera Prognostics is based in Salt Lake City, Utah.